CagriSema and the link between obesity and type 2 diabetes
Others are called dual-agonists, because in addition to promoting fullness they also increase the rate of metabolism
Starting at 2.5mg weekly, increasing to 5mg after four weeks, then 7.5mg, 10mg, 12.5mg, and potentially 15mg based on response and tolerance
In our experience, these results can be considered above average, which may be attributed to the users diligent dieting to lose the last 40 pounds, where they reported eliminating sugar and cheese from their diet
Licensed indications 2,3 2,3 Subcutaneous semaglutide (Wegovy) and tirzepatide (Mounjaro) are indicated as adjuncts to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial BMI of: 30 kg/m 2 (obesity), or 27 kg/m 2 to 2 days away, administer as soon as possible